Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Biomimetics are used in tissue engineering, regenerative medicine, and drug delivery. Medical Biomimetics mimics nature in a bid to improve the lives of humans. The increasing prevalence of chronic diseases such as cardiovascular diseases, increasing healthcare expenditure in developed and developing economies along with product developments are expected to propel demand for medical biomemetics market.

The global Medical Biomimetics market size was valued at US$ 26.2 billion in 2019, and is expected to exhibit a CAGR of 6.5% over the forecast period (2020–2027).

Figure 1: Global Medical Biomimetics market Value (US$ Bn), by Region, 2020

Medical Biomimetics  | Coherent Market Insights

The increasing incidence of chronic diseases is expected to fuel demand in global Medical Biomimetics market

The increasing prevalence of chronic diseases such as cardiovascular diseases in developed and developing economies is predicted to propel the growth of the Medical Biomimetics market during the forecast period. For instance, 2018, according to the Center for Disease Control and Prevention, coronary artery diseases are among the most common type of cardiovascular diseases in the U.S. because of which nearly 365,914 lost their lives in 2017.

Moreover, factors such as rising incidence of arthritis and the increasing focus on strengthening the healthcare infrastructure in the developing region are expected to drive growth of the Medical Biomimetics market in the near future. According to the World Health Organization’s 2017 estimates, around 9.6% men and 18.0% women over the age of 60 years symptomatic osteoarthritis worldwide.

Figure 2: Global Medical Biomimetics market Share (%) in terms of value, by Product Type, (2020-2027)

Medical Biomimetics  | Coherent Market Insights

Adoption of expansion strategies from major players operating in the market is expected to fuel the growth in Medical Biomimetics market

The growing prevalence of chronic diseases and other medical conditions is driving demand for efficient products. Therefore in order to cope up with the ever increasing demand for efficient localization products, manufacturers are focused on strengthening their market position by opening new offices in different locations. For instance, in February 2018, Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announced the opening of its new research facilities in Gaithersburg, Maryland., U.S.

Key Players

Major players operating in the global Medical Biomimetics market are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Abbott, Osteopore International Pte Ltd., and Applied Biomimetic.

Medical Biomimetics  Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 26.2 Bn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.5% 2027 Value Projection: US$ 43.4 Bn
Geographies covered:
  • North America: U.S.,Canada.
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, UK, Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • Product Type: Cardiovascular, Ophthalmology, Dental, Orthopedic, Others
  • Application: Wound Healing, Plastic Surgery, Drug Delivery, Others
Companies covered (8):

AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Abbott, Osteopore International Pte Ltd., and Applied Biomimetic

Growth Drivers:
  • The increasing incidence of cardiovascular diseases
  • The increasing research and development of products
  • The increasing healthcare expenditure in developed and developing economies
Restraints & Challenges:
  • High cost of Medical Biomimetics devices

Biomimetics are used for development of biocompatible material which allows healthcare professionals to monitor and treat chronic diseases such as cardiovascular disorders. Biomimetics have application in regenerative medicine, tissue engineering, and drug delivery. Incorporation of nanotechnology played a pivotal role for application in bone structures as well as drug delivery systems.

Market Dynamics

The increasing incidence of cardiovascular disorders, demand for prosthetics, implants for organ transplant, adoption of expansion strategies by manufacturers, product launches, along with the rising healthcare expenditure in developed and developing economies are the major factors driving the global medical biomimetic market growth. For instance, according to the Center for Medicare and Medicaid Center, healthcare spending grew by 4.6% in 2018 compared to 2017 and reached around US$ 3.6 Trillion in the U.S.

Furthermore, adoption of inorganic strategies such as mergers and acquisitions, expansion of production capabilities, new product development by key players for expanding their product portfolio in the market is expected to drive the market growth. For instance, in November 2019, Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies announced opening of new production facility in Gaithersburg, Maryland.

Key features of the study:

  • This report provides in-depth analysis of the global medical biomimetic market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global medical biomimetic market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Aboott, Osteopore International Pte Ltd., and Applied Biomimetic.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global medical biomimetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical biomimetic market.

Detailed Segmentation:

  • Global Medical Biomimetics Market, By Product Type:
    • Cardiovascular
    • Ophthalmology
    • Dental
    • Orthopedic
    • Others
  • Global Medical Biomimetics Market, By Application:
    • Wound Healing
    • Plastic Surgery
    • Drug Delivery
    • Others
  • Global Medical Biomimetics Market, By Region:
    • North America
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Cardiovascular
        • Ophthalmology
        • Dental
        • Orthopedic
        • Others
      • By Application:
        • Wound Healing
        • Plastic Surgery
        • Drug Delivery
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AVINENT Science and Technology*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • SynTouch Inc.
    • Wright Medical Group N.V.
    • EP Endovascular AB
    • Varian Medical Systems, Inc.
    • Abbott
    • Osteopore International Pte Ltd.
    • Applied Biomimetic.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Industry Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
    • PEST Analysis
  4. Global Medical Biomimetic Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Dental
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orthopedic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Medical Biomimetic Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Wound Healing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Plastic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Delivery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Medical Biomimetic Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • AVINENT Science and Technology
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SynTouch Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Wright Medical Group N.V.         
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • EP Endovascular AB
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Varian Medical Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Applied Biomimetic.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 18 figures on “Medical Biomimetic Market - Global forecast to 2027”.

Frequently Asked Questions

The global Medical Biomimetics market size was valued at US$ 26.2 billion in 2019 and is estimated to exhibit a CAGR of 6.5% between 2020 and 2027
Flexible Medical Biomimetics product type segment held the major market share in 2019 owing to an increasing number of product approvals during the forecast period.
Major factor driving the growth of global Medical Biomimetics market during the forecast period is the increasing prevalence of chronic diseases such as cardiovascular disorders, research and development, and adoption of expansion strategies.
Major factors hampering the growth of the medical biomemetics market during the forecast period constitutes of high cost of biomimetic implants and stringent regulation
North America Medical Biomimetics market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Cook Medical Inc., AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Abbott, Osteopore International Pte Ltd., and Applied Biomimetic
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner